Regulatory Filings • Oct 7, 2011
Regulatory Filings
Open in ViewerOpens in native device viewer
CONTACT | Media: +31.20.550.4488 (Amsterdam), +32.2.509.1392 (Brussels) +351.217.900.029 (Lisbon), +44.20.7379.2789 (London) +1.212.656.2411 (New York), +33.1.49.27.11.33 (Paris)
CONTACT | Investor Relations: +1.212.656.5700 (New York) +33.1.49.27.58.60 (Paris)
Double-Digit Growth in Trading Volumes Across All Venues Year-Over-Year Global Derivatives ADV Up 23%; U.S. Equity Options ADV Up 32% European Cash ADV Up 35%; U.S. Cash ADV Up 12%
October 7, 2011 – NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for September 20111 . Trading volumes across all venues were significantly higher year-over-year, but mostly declined sequentially from unseasonally strong levels in August 2011, which were driven by heightened market volatility in the U.S. and Europe. Global derivatives average daily volume ("ADV") of 9.5 million contracts in September 2011 increased 23.2% versus the prior year, driven by a 32.1% increase in U.S. options ADV. Cash equities ADV in September 2011 was strong, with European cash trading ADV increasing 34.6% and U.S. cash trading ADV increasing 12.3% from September 2010 levels.
1 All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.
decreased 19.8% compared to August 2011. NYSE Euronext's Tape A matched market share in September 2011 was 36.3%, down from 38.4% in September 2010, but up slightly from 36.2% in August 2011.
| 2Q11 Actual | 3Q11 Preliminary | |
|---|---|---|
| 1 European Derivatives (ex. Bclear) |
\$0.741 | \$0.69 |
| U.S. Equity Options2 | \$0.165 | \$0.15 |
| European Cash3 | \$0.742 | \$0.64 |
| U.S. Cash4 | \$0.039 | \$0.038 |
1 Average net revenue per contract, excluding Bclear.
2 Average net revenue per contract.
3 Average net revenue per transaction.
4 Average net revenue per 100 shares handled.
European Derivatives
The 2.2 million contracts in equity products ADV consisted of 1.5 million contracts in individual equity products ADV and 0.7 million contracts in equity index products ADV. The 1.5 million contracts in individual equity products ADV consisted of 1.0 million in futures contracts, which represented a 37.4% increase compared to September 2010 and 0.5 million in options contracts, which represented a 16.1% decrease compared to September 2010. The average net rate per contract for individual equity futures contracts is significantly lower than other products traded on NYSE Liffe. In the third quarter of 2011, total equity products ADV of 1.9 million contracts was 7.1% above prior year levels. Year-to-date, total equity products ADV of 2.3 million contracts was 12.2% below prior year levels.
• Total commodities products ADV of 91,000 contracts in September 2011 increased 18.8% compared to September 2010 and increased 35.8% compared to August 2011. In the third quarter of 2011, total commodities product ADV of 78,700 contracts was 3.4% below prior year levels. Year-to-date, total commodities product ADV of 84,000 contracts was 32.3% above prior year levels.
U.S. Derivatives
European Cash
U.S. Cash
In the third quarter of 2011, U.S. cash products handled ADV was 2.6 billion shares, up 8.8% from prior year levels.
Year-to-date, U.S. cash products handled ADV was 2.3 billion shares, down 14.2% from prior year levels.
Exchange Traded Funds
Please click here for the Monthly Transaction Activity Data Table.
NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets – the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca – represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the Fortune 500. For more information, please visit: http://www.nyx.com.
In connection with the proposed business combination transaction between NYSE Euronext and Deutsche Boerse AG, Alpha Beta Netherlands Holding N.V. ("Holding"), a newly formed holding company, filed, and the SEC declared effective on May 3, 2011, a Registration Statement on Form F-4 with the U.S. Securities and Exchange Commission ("SEC") that includes (1) a
proxy statement of NYSE Euronext that also constitutes a prospectus for Holding used in connection with NYSE Euronext special meeting of stockholders held on July 7, 2011 and (2) an offering prospectus used in connection with Holding's offer to acquire Deutsche Boerse AG shares held by U.S. holders. Holding has also filed an offer document with the German Federal Financial Supervisory Authority (Bundesanstalt fuer Finanzdienstleistungsaufsicht) ("BaFin"), which was approved by the BaFin for publication pursuant to the German Takeover Act (Wertpapiererwerbs-und Übernahmegesetz), and was published on May 4, 2011.
Investors and security holders are urged to read the definitive proxy statement/prospectus, the offering prospectus, the offer document, as amended, and published additional accompanying information in connection with the exchange offer regarding the proposed business combination transaction because they contain important information. You may obtain a free copy of the definitive proxy statement/prospectus, the offering prospectus and other related documents filed by NYSE Euronext and Holding with the SEC on the SEC's website at www.sec.gov. The definitive proxy statement/prospectus and other documents relating thereto may also be obtained for free by accessing NYSE Euronext's website at www.nyse.com. The offer document, as amended, and published additional accompanying information in connection with the exchange offer are available at Holding's website at www.global-exchange-operator.com.
This document is neither an offer to purchase nor a solicitation of an offer to sell shares of Holding, Deutsche Boerse AG or NYSE Euronext. The final terms and further provisions regarding the public offer are disclosed in the offer document that has been approved by the BaFin and in documents that have been filed with the SEC.
No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended, and applicable European regulations. The exchange offer and the exchange offer document as amended, shall not constitute an issuance, publication or public advertising of an offer pursuant to laws and regulations of jurisdictions other than those of Germany, United Kingdom of Great Britain and Northern Ireland and the United States of America. The relevant final terms of the proposed business combination transaction will be disclosed in the information documents reviewed by the competent European market authorities.
Subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the exchange offer will not be made directly or indirectly in or into Japan, or by use of the mails or by any means or instrumentality (including without limitation, facsimile transmission, telephone and the internet) of interstate or foreign commerce or any facility of a national securities exchange of Japan. Accordingly, copies of this announcement or any accompanying documents may not be, directly or indirectly, mailed or otherwise distributed, forwarded or transmitted in, into or from Japan.
The shares of Holding have not been, and will not be, registered under the applicable securities laws of Japan. Accordingly, subject to certain exceptions, in particular with respect to qualified institutional investors (tekikaku kikan toshika) as defined in Article 2 para. 3 (i) of the Financial Instruments and Exchange Act of Japan (Law No. 25 of 1948, as amended), the shares of Holding may not be offered or sold within Japan, or to or for the account or benefit of any person in Japan.
| Average Daily Volume | Total Volume | Average Daily Volume | Total Volume | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| (Unaudited; contracts in thousands) | Sep-11 | Sep-10 | % Chg | Sep-11 | Sep-10 | % Chg | YTD 2011 | % Chg vs. YTD 2010 |
YTD 2011 | % Chg vs. YTD 2010 |
| Number of Trading Days - European Markets Number of Trading Days - U.S. Markets |
22 21 |
22 21 |
22 21 |
22 21 |
193 189 |
193 189 |
||||
| European Derivatives Products | 4,809 | 4,238 | 13.5% | 105,799 | 93,235 | 13.5% | 4,752 | -6.5% | 917,115 | -6.0% |
| of which Bclear | 1,179 | 893 | 32.0% | 25,941 | 19,648 | 32.0% | 1,232 | -16.7% | 237,718 | -16.3% |
| Total Fixed Income Products | 2,547 | 2,229 | 14.2% | 56,029 | 49,048 | 14.2% | 2,399 | -1.5% | 462,950 | -1.0% |
| Short Term Interest Rate Products Medium and Long Term Interest Rate Products 1 |
2,400 147 |
2,110 120 |
13.8% 22.5% |
52,801 3,228 |
46,413 2,635 |
13.8% 22.5% |
2,258 141 |
-2.7% 21.0% |
435,804 27,146 |
-2.2% 21.6% |
| Total Equity Products 2 | 2,171 | 1,932 | 12.4% | 47,760 | 42,494 | 12.4% | 2,270 | -12.2% | 438,033 | -11.7% |
| Individual Equity Products | 1,483 | 1,319 | 12.5% | 32,636 | 29,021 | 12.5% | 1,675 | -14.5% | 323,229 | -14.0% |
| Futures Options |
967 517 |
703 | 37.4% 616 -16.1% |
21,266 11,369 |
15,475 | 37.4% 13,545 -16.1% |
1,063 612 |
-16.0% -11.7% |
205,169 118,060 |
-15.6% -11.3% |
| Equity Index Products | 687 | 612 | 12.2% | 15,124 | 13,474 | 12.2% | 595 | -4.8% | 114,805 | -4.3% |
| of which Bclear | 1,179 | 893 | 32.0% | 25,941 | 19,648 | 32.0% | 1,232 | -16.7% | 237,718 | -16.3% |
| Individual Equity Products Futures |
1,065 962 |
792 701 |
34.5% 37.1% |
23,431 21,154 |
17,427 15,432 |
34.5% 37.1% |
1,150 1,045 |
-16.7% -17.1% |
221,876 201,767 |
-16.3% -16.7% |
| Options | 104 | 91 | 14.2% | 2,277 | 1,995 | 14.2% | 104 | -12.9% | 20,109 | -12.5% |
| Equity Index Products | 114 | 101 | 12.9% | 2,509 | 2,222 | 12.9% | 82 | -16.8% | 15,841 | -16.4% |
| Commodity Products | 91 | 77 | 18.8% | 2,010 | 1,692 | 18.8% | 84 | 32.3% | 16,131 | 33.0% |
| U.S. Derivatives Products | ||||||||||
| Equity Options 3 | ||||||||||
| NYSE Euronext Options Contracts Total Consolidated Options Contracts |
4,588 17,134 |
3,473 13,319 |
32.1% 28.6% |
96,351 359,818 279,696 |
72,928 | 32.1% 28.6% |
4,445 17,187 |
21.6% 22.3% |
840,169 3,248,325 |
22.2% 22.9% |
| NYSE Group Share of Total | 26.8% | 26.1% | 26.8% | 26.1% | 25.9% | -0.1% | 25.9% | -0.1% | ||
| NYSE Liffe U.S. | ||||||||||
| Futures and Futures Options Volume* | 113.4 | 10.8 947.2% | 2,495 | 227 997.1% | 77.8 | 368.6% | 15,100.6 | 383.6% | ||
| European Cash Products (trades in thousands) | 1,882 | 1,399 | 34.6% | 41,402 | 30,770 | 34.6% | 1,753 | 18.2% | 338,267 | 18.8% |
| Equities | 1,804 | 1,341 34.5% | 39,684 | 29,508 34.5% | 1,684 | 18.3% | 325,084 | 18.9% | ||
| Exchange-Traded Funds | 26 | 17 56.1% | 576 | 369 56.1% | 21 | 15.6% | 3,988 | 16.2% | ||
| Structured Products Bonds |
47 5 |
35 34.7% 6 -14.4% |
1,037 106 |
770 34.7% 124 -14.4% |
43 5 |
19.5% -12.7% |
8,223 972 |
20.1% -12.3% |
||
| U.S. Cash Products (shares in millions) 5 | 2,558 | 2,278 | 12.3% | 53,709 47,829 | 12.3% | 2,333 | -14.2% | 440,850 | -13.8% | |
| NYSE Listed (Tape A) Issues 4 | ||||||||||
| Handled Volume 5 | 1,761 | 1,625 | 8.3% | 36,976 | 34,134 | 8.3% | 1,646 | -16.5% | 311,061 | -16.1% |
| Matched Volume 6 | 1,678 | 1,547 | 8.5% | 35,241 | 32,477 | 8.5% | 1,560 | -15.5% | 294,921 | -15.1% |
| Total NYSE Listed Consolidated Volume | 4,622 | 4,026 | 14.8% | 97,054 | 84,545 | 14.8% | 4,436 | -12.2% | 838,416 | -11.7% |
| Share of Total Consolidated Volume | ||||||||||
| Handled Volume 5 Matched Volume 6 |
38.1% | 40.4% | -2.3% | 38.1% | 40.4% | -2.3% | 37.1% | -1.9% | 37.1% | -1.9% |
| 36.3% | 38.4% | -2.1% | 36.3% | 38.4% | -2.1% | 35.2% | -1.4% | 35.2% | -1.4% | |
| NYSE Arca & Amex (Tape B) Listed Issues | ||||||||||
| Handled Volume 5 Matched Volume 6 |
477 432 |
339 311 |
40.9% 39.1% |
10,025 9,074 |
7,118 6,525 |
40.9% 39.1% |
384 346 |
-5.3% -5.0% |
72,582 65,340 |
-4.8% -4.5% |
| Total NYSE Arca & Amex Listed Consolidated Volume | 1,806 | 1,229 | 46.9% | 37,916 | 25,812 | 46.9% | 1,481 | -3.4% | 279,949 | -2.9% |
| Share of Total Consolidated Volume | ||||||||||
| Handled Volume 5 Matched Volume 6 |
26.4% | 27.6% | -1.2% | 26.4% | 27.6% | -1.2% | 25.9% | -0.5% | 25.9% | -0.5% |
| Nasdaq Listed (Tape C) Issues | 23.9% | 25.3% | -1.4% | 23.9% | 25.3% | -1.4% | 23.3% | -0.4% | 23.3% | -0.4% |
| Handled Volume 5 | 319 | 313 | 2.0% | 6,708 | 6,577 | 2.0% | 303 | -11.4% | 57,208 | -10.9% |
| Matched Volume 6 | 282 | 272 | 3.7% | 5,928 | 5,714 | 3.7% | 260 | -9.4% | 49,214 | -8.9% |
| Total Nasdaq Listed Consolidated Volume | 2,089 | 2,021 | 3.4% | 43,874 | 42,447 | 3.4% | 2,077 | -9.5% | 392,592 | -9.0% |
| Share of Total Consolidated Volume Handled Volume 5 |
||||||||||
| Matched Volume 6 | 15.3% 13.5% |
15.5% 13.5% |
-0.2% 0.0% |
15.3% 13.5% |
15.5% 13.5% |
-0.2% 0.0% |
14.6% 12.5% |
-0.3% 0.0% |
14.6% 12.5% |
-0.3% 0.0% |
| Exchange-Traded Funds 5,7 | ||||||||||
| Handled Volume 5 | 465 | 329 | 41.5% | 9,769 | 6,906 | 41.5% | 360 | -7.9% | 68,122 | -7.5% |
| Matched Volume 6 | 421 | 301 | 39.7% | 8,832 | 6,322 | 39.7% | 324 | -7.9% | 61,281 | -7.4% |
| Total ETF Consolidated Volume | 1,797 | 1,214 | 48.0% | 37,737 | 25,501 | 48.0% | 1,416 | -6.7% | 267,573 | -6.2% |
| Share of Total Consolidated Volume Handled Volume 5 |
||||||||||
| Matched Volume 6 | 25.9% 23.4% |
27.1% 24.8% |
-1.2% -1.4% |
25.9% 23.4% |
27.1% 24.8% |
-1.2% -1.4% |
25.5% 22.9% |
-0.3% -0.3% |
25.5% 22.9% |
-0.3% -0.3% |
7 Data included in previously identified categories.
* ADVs calculated with the appropriate number of NYSE Liffe U.S. trading.
Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.
All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.
5 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots.
4 Includes all volume executed in NYSE Group crossing sessions.
6 Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.
1 Data includes currency products.
2 Includes Bclear trading Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.
3 Includes trading in U.S. equity options contracts, not equity-index options.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.